Canal Cholesteatomas: Proposed Guidelines Based on Otologic Practices at a Tertiary Care Center
Otolaryngology–Head and Neck Surgery · 2025
DOI: 10.1002/ohn.1189 ↗At a glance
Leitlinie in Otolaryngology–Head and Neck Surgery, 2025. Written by Jan Ynav Quiz and 4 co-authors. Institution: Department of Otolaryngology-Head and Neck Surgery, University of Florida School of Medicine, Gainesville, Florida, USA. Major MEDLINE topics: Ear Canal, Practice Guidelines as Topic, Cholesteatoma. 24 references.
Abstract (original language)
Objective
This study aims to analyze disease and treatment patterns at a tertiary care center and propose guidelines for the management of canal cholesteatomas. Study Design A retrospective cohort study.
Setting
This study involves patients diagnosed and treated with external auditory canal cholesteatomas (EACC) from January 1, 2010, to January 1, 2021 at the University of Florida, a tertiary care center.
Methods
Inclusion criteria included a diagnosis of EACC with at least 1 follow‐up visit after diagnosis. Patient demographics, risk factors, etiology if acquired, EACC characteristics such as location and staging, and treatment modality were recorded and analyzed. The primary outcome was a recurrence of disease.
Results
Out of the 175 patients reviewed, 90 patients and 100 ears met the criteria. Most patients were treated with surgery (81%, N = 81) as opposed to medical management (ie, serial debridement). While there were no factors that were significant for higher odds of surgical intervention, all Stage IV (n = 9) and superior canal wall locations (n = 8) were treated with surgery. Mastoidectomy was more likely to be performed in higher staged cholesteatomas ( χ 2 = 13.41, P = .0012) and posterior canal cholesteatoma location (odds ratio [OR] = 11.20, P = .0001), whereas anterior (OR = 0.11, P = .0390) and inferiorly located EACCs (OR = 0.22, P = .0169) had more odds of being treated with canalplasty/tympanoplasty. Recurrence was seen up to 4.78 years after surgery.
Conclusion
Disease location and staging and patient factors should be considered in the shared management decision‐making of EACC treatment. Surveillance duration should be up to 5 years.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Otolaryngology-Head and Neck Surgery, University of Florida School of Medicine, Gainesville, Florida, USA.
Cite
APA
Quiz, J. Y., Vijay, A., Lovett, B., Mueller, L., & Haberman, R. (2025). Canal Cholesteatomas: Proposed Guidelines Based on Otologic Practices at a Tertiary Care Center. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.1189
Vancouver
Quiz JY, Vijay A, Lovett B, Mueller L, Haberman R. Canal Cholesteatomas: Proposed Guidelines Based on Otologic Practices at a Tertiary Care Center. Otolaryngology–Head and Neck Surgery. 2025. doi:10.1002/ohn.1189
BibTeX
@article{Quiz2025,
author = {Quiz, Jan Ynav and Vijay, Arunima and Lovett, Braeden and Mueller, Lauren and Haberman, Rex},
title = {Canal Cholesteatomas: Proposed Guidelines Based on Otologic Practices at a Tertiary Care Center},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2025},
doi = {10.1002/ohn.1189}
}
EUVIMED